Hester Biosciences Limited (BSE: 524669)
Health Care · Biotechnology · IN
Rs2,041.90
-4.61% today · +17.3% 1Y
Hester Biosciences Limited (BSE: 524669) operates in the Biotechnology industry within the Health Care sector. The company is valued at $179.48M.
Over the last twelve months the share price has gained 17.3%, trading between 1.25K and 2.67K.
Tweenvest scores Hester Biosciences Limited across four factors: quality 77/100, value 59/100, growth 68/100, dividend 68/100. Its strongest factor is quality.
524669 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $179.48M
- Revenue (TTM)
- $34.61M
- P/E
- 12.92
- EPS
- 158.03
- Dividend yield
- 0.54%
- Beta (5Y)
- 0.43
- 52-week high
- Rs2,669.00
- 52-week low
- Rs1,250.95
- Avg volume (3M)
- —
- Shares outstanding
- 8.51M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thor Medical ASAOB: TRMED | $196.75M | Nkr4.46 | -1.00% |
| IntoCell, Inc.KOSDAQ: A287840 | $193.53M | ₩17,320.00 | -4.04% |
| Adagene Inc.NasdaqGM: ADAG | $185.32M | $2.74 | -0.72% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $180.24M | $6.53 | -2.83% |
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $178.83M | $0.94 | -5.59% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $178.78M | $24.61 | -11.03% |
| Uwell Biopharma, Inc.TPEX: 7902 | $175.67M | NT$28.00 | -4.92% |
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $174.23M | $1.26 | +0.80% |
Figures last refreshed Oct 11, 2026.